Presentations

Importancia de la Estratificación de Riesgo en SCA

solaci
solaci
241
0

6_jose-luis_leiva_pons
José Luis Leiva Pons
2014-10-30

Secretario SOLACI 
Jefe de Cardiología Intervencionista
Hospital Central “Dr. I. Morones Prieto”
Facultad de Medicina UASLP
San Luis Potosí, S.L.P. MEXICO

Previous article
Manejo de las lesiones de TASC A a TASC D
Next article
CoreValve for High Risk and Extreme Risk Patients; The US Pivotal Trials
solaci
solaci

More articles by this author

Stroke

solaci - 0
Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

Intervencionismo Coronario en Venas Centrales

solaci - 0
Jorge Villegas2014-10-30Cardiólogo IntervencionistaProfesor: F.U.C.S.Jefe de Hemodinmia Hospital Universitario Clínica San Rafael

TAVI-Induced Conduction Abnormalities

solaci - 0
Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands

In Perspective: Impact of new TAVI Devices on TAVI Complications

solaci - 0
Eberhard Grube2014-10-30MD, FACC, FSCAIUniversity Hospital, Dept of Medicine II, Bonn, GermanyStanford University, Palo Alto, California, USA 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Presentations

Stroke

Rutger-Jan Nuis 2014-10-30MD, MSc, PhDDepartment of CardiologyThoraxcenter Rotterdam, Netherlands
solaci -
SOLACI Sessionsspot_img

Recent Articles

Bioresorbable devices vs DES in patients at high risk of restenosis. Seven-year follow-up of the COMPARE-ABSORB trial

Dr. Andrés Rodríguez - 0
Studies with second-generation drug-eluting stents (DES) have shown that the rate of target lesion failure (TLF) increases linearly up to 5–10 years of follow-up,...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Dr. Juan Manuel Pérez - 0
Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Dr. Juan Manuel Pérez - 0
Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...